tetramethylpyrazine has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Chen, Y; Li, J; Li, L; Li, Y; Wang, H; Wang, Q; Yang, D; Yu, B; Zhai, J; Zhang, H; Zhang, P; Zhao, X | 1 |
| Chen, S; Jiang, F; Liu, C; Qian, J; Zhang, W | 1 |
1 trial(s) available for tetramethylpyrazine and Dyslipidemia
| Article | Year |
|---|---|
Effect of DLT-SML on Chronic Stable Angina Through Ameliorating Inflammation, Correcting Dyslipidemia, and Regulating Gut Microbiota.
Topics: Adult; Aged; Angina, Stable; Anti-Inflammatory Agents; Bacteria; Biomarkers; China; Cytokines; Drug Therapy, Combination; Drugs, Chinese Herbal; Dysbiosis; Dyslipidemias; Female; Gastrointestinal Microbiome; Humans; Hypolipidemic Agents; Inflammation; Inflammation Mediators; Lipids; Male; Methylamines; Middle Aged; Pyrazines; Time Factors; Treatment Outcome | 2021 |
1 other study(ies) available for tetramethylpyrazine and Dyslipidemia
| Article | Year |
|---|---|
Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress.
Topics: Animals; Antioxidants; Aorta, Thoracic; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Dyslipidemias; Ligusticum; Lipid Metabolism; Liver; Liver Function Tests; Male; Oxidative Stress; Phytotherapy; Pyrazines; Rats; Rats, Sprague-Dawley; Rhizome; Triglycerides; Vasodilator Agents | 2011 |